首页|期刊导航|现代中西医结合杂志|健脾疏肝降脂方通过调节FGF21/PGC-1α/UCP1信号通路促进单纯性肥胖小鼠白色脂肪棕色化机制研究

健脾疏肝降脂方通过调节FGF21/PGC-1α/UCP1信号通路促进单纯性肥胖小鼠白色脂肪棕色化机制研究OA

Jianpi Shugan Jiangzhi Formula promotes browning of white adipose tissue in simple obesity mice via regulating the FGF-21/PGC-1α/UCP-1 signaling pathway

中文摘要英文摘要

目的 基于成纤维细胞生长因子21(FGF21)/过氧化物酶体增殖物激活受体 γ 共激活因子-1α(PGC-1α)/解偶联蛋白1(UCP1)信号通路,探讨健脾疏肝降脂方对单纯性肥胖小鼠的干预作用.方法 取72 只 C57BL/6J 雄性小鼠,随机选择其中12 只作为正常组,其余小鼠给予高脂饲料喂养建立肥胖模型.将造模成功的小鼠随机分为模型组、阿托伐他汀组、健脾疏肝降脂方高剂量组、健脾疏肝降脂方中剂量组、健脾疏肝降脂方低剂量组,每组12 只.健脾疏肝降脂方高、中、低剂量组分别给予26.52 g(生药)/kg、13.26 g(生药)/kg、6.63 g(生药)/kg 的健脾疏肝降脂方药液灌胃,阿托伐他汀组给予1.3 mg/kg 的阿托伐他汀药液灌胃,正常组和模型组给予双蒸水灌胃,均每天1 次,持续灌胃8 周.末次灌胃结束后称量各组小鼠体重,检测肝功能指标[丙氨酸氨基转移酶(ALT)、谷氨酸氨基转移酶(AST)]及血脂指标[总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)],HE 染色观察脂肪细胞形态,免疫荧光法检测脂肪组织中 FGF21、PGC-1α、过氧化物酶体增殖物激活受体 γ(PPARγ)、UCP1 阳性表达情况,Real-time PCR 和 Western blot 法分别检测脂肪组织中 FGF21、PGC-1α、PPARγ、UCP1 mRNA和蛋白表达情况.结果 与正常组比较,模型组小鼠体重明显增加(P<0.05),血清 ALT、AST、LDL-C、TC、TG 水平均明显升高(P 均<0.05),血清 HDL-C 水平明显降低(P<0.05);脂肪细胞排列不规则,脂肪细胞直径明显变大,单位面积中脂肪细胞数量减少;脂肪组织中 FGF21、PGC-1α、PPARγ、UCP1 荧光信号强度和 mRNA 相对表达量(PPARγ 除外)及蛋白相对表达量均变化不明显(P 均>0.05).与模型组比较,健脾疏肝降脂方高剂量组和阿托伐他汀组小鼠体重明显减轻(P 均<0.05),血清 ALT、AST、LDL-C、TC、TG 水平均明显降低(P 均<0.05);脂肪细胞排列稍显规则,脂肪细胞直径减小,单位面积中脂肪细胞数量有所增加;脂肪组织中 FGF21、PGC-1α、PPARγ、UCP1 荧光信号强度和 mRNA 相对表达量及蛋白相对表达量均明显升高(P 均<0.05);与阿托伐他汀组比较,健脾疏肝降脂方高剂量组脂肪组织中 FGF21、PPARγ 荧光信号强度和 FGF21、UCP1 mRNA 及蛋白相对表达量均明显升高(P 均<0.05).结论 健脾疏肝降脂方可减轻单纯性肥胖小鼠体重,改善脂代谢紊乱,其机制可能与调控脂肪组织 FGF21/PGC-1α/PPARγ/UCP1 信号通路,促进白色脂肪棕色化有关.

Objective It is to explore the effect of Jianpi Shugan Jiangzhi Formula(JSJF)on simple obesity in mice via fibroblast growth factor 21(FGF21)/peroxisome proliferator-activated receptor γ coactivator-1α(PGC-1α)/uncoupling pro-tein 1(UCP1).Methods Seventy-two male C57BL/6J mice were taken,12 of which were randomly selected as normal group,and the remaining mice were fed with high fat diet to establish models of obesity.The successfully modeled mice were randomly divided into model group,atorvastatin group,high-dose,medium-dose and low-dose groups of JSJF,with 12 mice in each group.The high-dose,medium-dose and low-dose groups of JSJF were given JSJF 26.52 g(crude drug)/kg,13.26 g(crude drug)/kg,6.63 g(crude drug)/kg via gastric lavage,respectively;the atorvastatin group was given 1.3 mg/kg atorvastatin solution via gastric lavage,while the control group and model group were given double-distilled water via gastric lavage,all once daily,continuously treated for 8 weeks.All groups received the solution once daily at a dose of 0.2 mL per administration for 8 weeks.After the final gavage,the body weights of mice in each group were measured,and the liver function markers[alanine aminotransferase(ALT),aspartate aminotransferase(AST)]and blood lipid markers[total cholesterol(TC),triglycerides(TG),high-density lipoprotein cholesterol(HDL-C),low-density lipoprotein cholesterol(LDL-C)]were measured,the adipocyte morphology was observed by HE staining,and the positive expressions of FGF21,PGC-1α,peroxisome proliferator-activated receptor γ(PPARγ)and UCP1 in adipose tissue were detected by immunofluo-rescence,the mRNA and protein expressions of FGF21,PGC-1α,PPARγ,and UCP1 in adipose tissue were detected by Real-time PCR and Western blot,respectively.Results Compared with the control group,the body weight of mice in the model group was significantly increased(P<0.05),and the serum levels ofALT,AST,LDL-C,TC,and TG were all significantly increased(all P<0.05),while the serum level of HDL-C was significantly reduced(P<0.05);the adipo-cytes were irregularly arranged,and their diameters were significantly increased,the number of adipocytes per unit area was decreased;the fluorescence signal intensity and relative mRNA and protein expressions of FGF21,PGC-1α,PPARγ and UCP1 in adipose tissue(except for mRNA expression of PPARγ)were not significantly changed(all P>0.05).Compared with the control group,the body weights of mice in the high-dose group of JSJF and atorvastatin group were significantly lighter(all P<0.05),and the serum levels ofALT,AST,LDL-C,TC and TG were all significantly lower(all P<0.05);the adipocyte arrangement was slightly more regular,their diameters were decreased,and the numbers of adipo-cytes per unit area were increased;the fluorescence signal intensity and relative mRNA and protein expressions of FGF21,PGC-1α,PPARγ and UCP1 in adipose tissue were all significantly increased(all P<0.05);compared with the atorvasta-tin group,the fluorescence signal intensities of FGF21 and PPARγ,as well as relative mRNA and protein expressions of FGF21 and UCP1 in adipose tissue were significantly increased in the high-dose group of JSJF(all P<0.05).Conclusion JSJF can reduce body weight and improve lipid metabolism disorders of mice with simple obesity;its mechanism of action may be related to the regulation of the FGF21/PGC-1α/PPARγ/UCP1 signaling pathway in adipose tissue to promote the browning of white fat.

陈建;于文文;曾莉;应汝炯;吴丽琳;董云;沈洁;盛昭园

上海中医药大学附属上海市中西医结合医院,上海 200082上海中医药大学附属上海市中西医结合医院,上海 200082上海市第七人民医院,上海 200135上海中医药大学附属上海市中西医结合医院,上海 200082上海中医药大学附属上海市中西医结合医院,上海 200082上海中医药大学附属上海市中西医结合医院,上海 200082上海中医药大学附属上海市中西医结合医院,上海 200082上海中医药大学附属上海市中西医结合医院,上海 200082

医药卫生

单纯性肥胖白色脂肪棕色化健脾疏肝降脂方成纤维细胞生长因子21过氧化物酶体增殖物激活受体γ共激活因子-1α解偶联蛋白1

simple obesitybrowning of white fatJianpi Shugan Jiangzhi FormulaFGF-21PGC-1αUCP1

《现代中西医结合杂志》 2026 (16)

2225-2234,10

上海市卫生健康委员会"海派中医流派传承延伸计划"[ZY(2021-2023)-0209-07]"十四五"中医特色专科建设(肌病专科)(ZYTSZK2-5)虹口区第二轮"国医强优"三年行动计划(2022-2024年)(HKGYQYXM-2022-15)上海市虹口区卫生健康委员会中医药科研课题(HKQGYQY-ZYY-2023-05,HKQGYQY-ZYY-2023-04,HKQ-ZYY-2021-01)上海中医药大学第二十期课程建设项目(SHUTCM2021KC180)上海中医药大学第二十二期课程建设项目(2023SHUTCMKCJS153)上海中医药大学科技发展基金资助项目(23KFL087)

10.3969/j.issn.1008-8849.2026.16.006

评论